Why Verastem Stock Is Plunging Today [The Motley Fool]
Verastem, Inc. (VSTM)
Last verastem, inc. earnings: 10/29 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
verastem.com
Company Research
Source: The Motley Fool
The biotech is raising cash ahead of a potential launch of its first drug. Brian Orelli ( TMFBiologyFool ) May 16, 2018 at 12:48PM What happened Shares of Verastem ( NASDAQ:VSTM ) are plunging today, down 11% as of 11:53 a.m. EDT, after the company announced that it sold 7,777,778 shares at $4.50 per share in a secondary offering, a substantial discount to yesterday's closing price of $5.24. Image source: Getty Images. So what Shares of Verastem have been on a tear over the last week for no apparent reason, which likely explains why management decided to raise capital. The higher the selling price, the less current investors are diluted. VSTM data by YCharts . The secondary offering will gross Verastem $35 million with the possibility of raising another $5.25 million if the underwriters use their option to purchase addition
Show less
Read more
Impact Snapshot
Event Time:
VSTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VSTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VSTM alerts
High impacting Verastem, Inc. news events
Weekly update
A roundup of the hottest topics
VSTM
News
- Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.MarketBeat
- Verastem, Inc. (NASDAQ: VSTM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $32.00 price target on the stock.MarketBeat
- Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian CancerBusiness Wire
- Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates [Yahoo! Finance]Yahoo! Finance
- Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business UpdatesBusiness Wire
VSTM
Earnings
- 3/14/24 - Miss
VSTM
Sec Filings
- 3/27/24 - Form 4
- 3/21/24 - Form 4
- 3/20/24 - Form 4
- VSTM's page on the SEC website